Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma

Obesity, metabolic syndrome (MetS) and type 2 diabetes (T2D) are associated with decreased cognitive function. While weight loss and T2D remission result in improvements in metabolism and vascular function, it is less clear if these benefits extend to cognitive performance. Here, we highlight the ma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EBioMedicine
Autors principals: Johnson, Lance A., Zuloaga, Kristen L., Kugelman, Tara L., Mader, Kevin S., Morré, Jeff T., Zuloaga, Damian G., Weber, Sydney, Marzulla, Tessa, Mulford, Amelia, Button, Dana, Lindner, Jonathan R., Alkayed, Nabil J., Stevens, Jan F., Raber, Jacob
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2015
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4739422/
https://ncbi.nlm.nih.gov/pubmed/26870815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2015.12.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars